Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|November 24, 2021
Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutationsLyudmila Bazhenova, Anna Minchom, Santiago Viteri, et al.
BMJ Open|September 7, 2021
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)Abhijit Pal, Sarah Stapleton, Christina Yap, et al.
Molecular Cancer Therapeutics|April 3, 2022
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic ChangesElizabeth A Coker, Adam Stewart, Bugra Ozer, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancerWanyuan Cui, Charlotte Milner-Watts, Terri P McVeigh, et al.
BMC Cancer|December 10, 2020
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Molecular Oncology|October 21, 2022
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasetsSantiago Viteri, Anna Minchom, Lyudmila Bazhenova, et al.
Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.
Future Oncology (London, England)|January 6, 2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumorsEcaterina Dumbrava, Anna Minchom, Jason Henry, et al.
Oncology|April 16, 2016
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural EffusionsMartina Puglisi, Adam Stewart, Parames Thavasu, et al.
Lung Cancer Management|June 4, 2021
HER3 expression and MEK activation in non-small-cell lung carcinomaThubeena Manickavasagar, Wei Yuan, Suzanne Carreira, et al.
Pageof 7